Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Castegnaro

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|June 25, 1998
Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adductionM Castegnaro, U Mohr, A Pfohl-Leszkowicz, et al.
Cancer Research|November 15, 1992
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activityK Alexandrov, M Rojas, O Geneste, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposureM Castegnaro, L Garren, D Galendo, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|January 1, 1996
Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathyI G Nikolov, D Petkova-Bocharova, M Castegnaro, et al.
Carcinogenesis|April 1, 1991
32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agentM Peluso, M Castegnaro, C Malaveille, et al.
Carcinogenesis|July 1, 1991
Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokersO Geneste, A M Camus, M Castegnaro, et al.
IARC Scientific Publications|January 1, 1984
Destruction of carcinogenic and mutagenic N-nitrosamides in laboratory wastesG Lunn, E B Sansone, A W Andrews, et al.
IARC Scientific Publications|January 1, 1982
Laboratory decontamination and destruction of carcinogens in laboratory wastes: some N-nitrosaminesM Castegnaro, G Eisenbrand, G Ellen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1986
Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquineE Hietanen, C Malaveille, A M Camus, et al.
Mutation Research|September 1, 1991
Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patientsH Bartsch, S Petruzzelli, S De Flora, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|June 25, 1998
Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adductionM Castegnaro, U Mohr, A Pfohl-Leszkowicz, et al.
Cancer Research|November 15, 1992
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activityK Alexandrov, M Rojas, O Geneste, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposureM Castegnaro, L Garren, D Galendo, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|January 1, 1996
Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathyI G Nikolov, D Petkova-Bocharova, M Castegnaro, et al.
Carcinogenesis|April 1, 1991
32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agentM Peluso, M Castegnaro, C Malaveille, et al.
Carcinogenesis|July 1, 1991
Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokersO Geneste, A M Camus, M Castegnaro, et al.
IARC Scientific Publications|January 1, 1984
Destruction of carcinogenic and mutagenic N-nitrosamides in laboratory wastesG Lunn, E B Sansone, A W Andrews, et al.
IARC Scientific Publications|January 1, 1982
Laboratory decontamination and destruction of carcinogens in laboratory wastes: some N-nitrosaminesM Castegnaro, G Eisenbrand, G Ellen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1986
Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquineE Hietanen, C Malaveille, A M Camus, et al.
Mutation Research|September 1, 1991
Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patientsH Bartsch, S Petruzzelli, S De Flora, et al.
Pageof 12